Fjarde Ap-fonden’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-99,500
Closed -$2.98M 575
2021
Q3
$2.98M Sell
99,500
-2,800
-3% -$96.3K 0.03% 510
2021
Q2
$3.71M Sell
102,300
-13,500
-12% -$501K 0.03% 483
2021
Q1
$4.24M Buy
115,800
+10,300
+10% +$379K 0.04% 441
2020
Q4
$3.83M Buy
105,500
+14,800
+16% +$502K 0.04% 451
2020
Q3
$2.72M Buy
90,700
+1,400
+2% +$43.7K 0.03% 497
2020
Q2
$2.65M Sell
89,300
-18,200
-17% -$539K 0.03% 482
2020
Q1
$2.85M Buy
107,500
+24,200
+29% +$918K 0.05% 393
2019
Q4
$3.53M Buy
+83,300
New +$3.53M 0.04% 449

Other funds holding OHI

Fjarde Ap-fonden's OHI Position: Q4 2021 in Review

Fjarde Ap-fonden sold out of Omega Healthcare (OHI) in Q4 2021, closing a stake of 99,500 shares — an estimated $2.98M sold.

Fjarde Ap-fonden first reported a position in OHI in Q4 2019 and held it in 8 quarters. The position peaked at $4.24M in Q1 2021. 496 funds tracked by Wall St. Rank hold OHI as of Q4 2021.

  • Fjarde Ap-fonden reported no remaining Omega Healthcare position as of Q4 2021 after selling out during the quarter.
  • Fjarde Ap-fonden sold 99,500 Omega Healthcare shares in Q4 2021, an estimated $2.98M.
  • Fjarde Ap-fonden first reported a position in Omega Healthcare in Q4 2019 and held it in 8 quarters.
  • Fjarde Ap-fonden's Omega Healthcare position peaked at $4.24M in Q1 2021.
  • 496 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2021.

Based on Fjarde Ap-fonden's 13F filing for Q4 2021, filed 15 Feb 2022.